ORBIMED ADVISORS LLC: NTRA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on NTRA, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 262,000 NTRA shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 262,000 sharesChange vs previous 13F 0 shares
1.35% of the 13F portfolio, value $71,119,900.
13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 262,000 sharesChange vs previous 13F -103,800 shares
1.14% of the 13F portfolio, value $52,397,380.
13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 365,800 sharesChange vs previous 13F -63,500 shares
1.71% of the 13F portfolio, value $83,801,122.
13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 429,300 sharesChange vs previous 13F -164,134 shares
1.66% of the 13F portfolio, value $69,104,421.
13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 593,434 sharesChange vs previous 13F +46,434 shares
2.52% of the 13F portfolio, value $100,254,740.
13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 547,000 sharesChange vs previous 13F +134,000 shares
1.86% of the 13F portfolio, value $77,351,270.
13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 413,000 sharesChange vs previous 13F -274,500 shares
1.36% of the 13F portfolio, value $65,377,900.
13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 687,500 sharesChange vs previous 13F not available
1.6% of the 13F portfolio, value $87,278,125.
13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).